In a prospective randomised study the effect of flutamide 750 mg daily was compared with
that of stilboestrol 3 mg daily in the treatment of 40 previously untreated patients with …

OBJECTIVE To compare the efficacy and tolerability of peripheral androgen blockade using
combined low‐dose flutamide plus finasteride vs low‐dose flutamide monotherapy for …

PURPOSE: Gastrointestinal (GI) side effects of flutamide in cases treated for advanced
prostate cancer are well documented. Proposed mechanisms for these side effects include …

PURPOSE: Time to progression (TTP), overall survival, and quality of life (QL) were
compared in patients with hormone-resistant prostate cancer (HRPC) treated with …

PURPOSE: We assess the impact of deferred flutamide treatment on the serum prostate
specific antigen (PSA) level in patients with localized or metastatic cancer. MATERIALS AND …

Evolution of the roles proposed for antiandrogenic agents in prostatic disease has been
rapid. Since the early suggestions by Labrie and his colleagues that the nonsteroidal …

Correspondence Page 1 Correspondence Primary urethral transitional cell carcinoma in a
female Sir, I was particularly interested in this paper [1]; we published our experiences of 10 …

There is a marked decrease in the prevalence and extent of high-grade prostatic
intraepithelial neoplasia (PIN) in men with prostate cancer after androgen deprivation …

OBJECTIVES: To report the efficacy of castration after progression on finasteride and
flutamide. Standard androgen deprivation strategies for prostate cancer typically lead to …

A double-blind study comparing the efficacy of flutamide (SCH-13521) and diethylstilbestrol
in 15 patients with advanced, previously untreated adenocarcinoma in the prostate is herein …